Parallel Versus Perpendicular Technique for Lumbar Medial Branch Radiofrequency Neurotomy
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Byron Schneider, MD · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
- Blake Fechtel, MD MSc · STUDY_DIRECTOR · Vanderbilt University Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Modified Clinical Outcome Measurement Brief Instrument (COMBI), Global Impression of ChangeBaseline to 12 months
Global Impression of Change; Range 0-7 0 = Very much improved 7 = Very much worse
- Change in Modified Clinical Outcome Measurement Brief Instrument (COMBI), Numeric Rating Scale of Pain IntensityBaseline to 12 months
Numeric Rating Scale of Pain Intensity; Range 0-10 0 = No pain 10 = Pain as bad as you can imagine
- Change in Modified Clinical Outcome Measurement Brief Instrument (COMBI), PainBaseline to 12 months
Pain sub-scale as part of the Pain, Enjoyment, General Activity domain of COMBI; Range 0-10 0 = No Pain 10 = Pain as bad as you can image
- Change in Modified Clinical Outcome Measurement Brief Instrument (COMBI), EnjoymentBaseline to 12 months
Enjoyment sub-scale as part of the Pain, Enjoyment, General Activity domain of COMBI; Range 0-10 0 = Does not interfere 10 = Completely interferes
- Change in Modified Clinical Outcome Measurement Brief Instrument (COMBI), General ActivityBaseline to 12 months
General Activity sub-scale as part of the Pain, Enjoyment, General Activity domain of COMBI; Range 0-10 0 = Does not interfere 10 = Completely interferes
- Change in Modified Clinical Outcome Measurement Brief Instrument (COMBI), Number of Participants Not Requiring Other HealthcareBaseline to 12 months
Categorical Outcome; ideal would be that patients no longer require other care for the condition for which they were treated. So, the scoring is simply absolute. The instrument is neither designed nor intended for more granular analysis, on the grounds that partial reduction in doses required, but nevertheless continuation of other treatment, falls short of indicating a worthwhile, successful outcome (PubMed Identifier: 25312899).
- Change in Modified Clinical Outcome Measurement Brief Instrument (COMBI), Number of Participants Returning to WorkBaseline to 12 months
Categorical outcome; it is very relevant if return to work is achieved. Failure to return to work is too vexatious an issue, with so many determinants that it is neither efficient nor effective to bother trying to record them (Reference PMID: 25312899).
- Change in Oswestry Disability Index (ODI)Baseline to 12 months
The questionnaire is designed to give information on how pain is affecting the ability to manage everyday life. The range of scores is 0-100%. 0-20%: "minimal disability": The patient can cope with most living activities. Usually no treatment is indicated apart from advice on lifting sitting and exercise. 21-40%: "moderate disability": The patient experiences more pain and difficulty with sitting, lifting and standing. Travel and social life are more difficult and they may be disabled from work. Personal care, sexual activity and sleeping are not grossly affected and the patient can usually be managed by conservative means. 41-60%: "severe disability": Pain remains the main problem in this group but activities of daily living are affected. 61-80%: "crippled": Back pain impinges on all aspects of the patient's life. 81-100%: These patients are either bed-bound or exaggerating their symptoms.